Cargando…
Study of the physicochemical properties of drugs suitable for administration using a lymphatic drug delivery system
Lymph node (LN) metastasis is thought to account for 20‐30% of deaths from head and neck cancer. The lymphatic drug delivery system (LDDS) is a new technology that enables the injection of drugs into a sentinel LN (SLN) during the early stage of tumor metastasis to treat the SLN and secondary metast...
Autores principales: | Fukumura, Ryoichi, Sukhbaatar, Ariunbuyan, Mishra, Radhika, Sakamoto, Maya, Mori, Shiro, Kodama, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088917/ https://www.ncbi.nlm.nih.gov/pubmed/33629407 http://dx.doi.org/10.1111/cas.14867 |
Ejemplares similares
-
Treatment of false‐negative metastatic lymph nodes by a lymphatic drug delivery system with 5‐fluorouracil
por: Fujii, Honoka, et al.
Publicado: (2019) -
Drug formulation augments the therapeutic response of carboplatin administered through a lymphatic drug delivery system
por: Mishra, Radhika, et al.
Publicado: (2022) -
Combination therapy of lymphatic drug delivery and total body irradiation in a metastatic lymph node and lung mouse model
por: Sora, Shota, et al.
Publicado: (2022) -
Intranodal pressure of a metastatic lymph node reflects the response to lymphatic drug delivery system
por: Kato, Shigeki, et al.
Publicado: (2020) -
Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia
por: Mishra, Radhika, et al.
Publicado: (2023)